Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dengyao Liu"'
Autor:
Pan Hu, Letao Lin, Tao Huang, Zhenyu Li, Meigui Xiao, Huanqing Guo, Guanyu Chen, Dengyao Liu, Miaola Ke, Hongbo Shan, Fujun Zhang, Yanling Zhang
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-16 (2023)
Abstract Background Hepatocellular carcinoma (HCC) has a high incidence and mortality rate despite various treatment options, including 125I seed implantation. However, recurrence and radiation resistance remain challenging issues. Hsa_circ_0007895 (
Externí odkaz:
https://doaj.org/article/58be9ac67fc54c56beec3a9dd9371deb
Publikováno v:
Mammalian genome : official journal of the International Mammalian Genome Society. 33(3)
Live cancer is the sixth most prevalent diagnosed malignant tumor and the fourth leading cause of cancer-related deaths worldwide. Hepatocellular carcinoma (HCC) is the main histological type of liver cancer. Here, we attempt to evaluate the role of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf51c2249ec0417f555d207e57b32227
https://pubmed.ncbi.nlm.nih.gov/35357550
https://pubmed.ncbi.nlm.nih.gov/35357550
Autor:
Wukui, Huang, Lina, You, Dengyao, Liu, Shufa, Yang, Mo, Liu, Hailin, Wang, Pingju, Wang, Pahaerding, Baikere, Peng, Gu, Abulajiang, Abulikemu, Shaoha, Yuan, Xiwen, Fan
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(6)
To assess the efficacy and safety of S-1 plus sorafenib for the treatment of advanced hepatocellular carcinoma (HCC).PubMed, the Cochrane Library, EMBASE, and ClinicalTrials.gov were searched using the terms "Hepatocellular Carcinoma" or "HCC" or "He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1c69a88aeed62a4fa0c87625e48ce6a6
https://pubmed.ncbi.nlm.nih.gov/28039697
https://pubmed.ncbi.nlm.nih.gov/28039697
Autor:
Wukui, Huang, Lina, You, Shufa, Yang, Dengyao, Liu, Mo, Liu, Hailin, Wang, Pingju, Wang, Pahaerding, Baikere, Peng, Gu, Abulajiang, Abulikemu, Shaoha, Yuan, Xiwen, Fan
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(4)
To assess the efficacy and safety of metronomic S-1 chemotherapy combination with transcatheter arterial chemoembolization (TACE) for the treatment of Barcelona Clinic Liver Cancer (BCLC) Stage B hepatocellular carcinoma (HCC) refractory to TACE.Twen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::075fa8d538b156ac9a856abe569d20eb
https://pubmed.ncbi.nlm.nih.gov/27685913
https://pubmed.ncbi.nlm.nih.gov/27685913